Variables | Fluid replacement rate; ml/kg/min | Â | |||
---|---|---|---|---|---|
≥ 0.5, N = 256 | 0.25–0.49, N = 123 | 0.17–0.24, N = 88 | < 0.17, N = 585 | P value | |
Time to shock reversal; days |  |  |  |  | < .001‡ |
N | 232 | 103 | 73 | 506 | Â |
 Median (Q1, Q3) | 1.6 (0.9, 3.3) | 1.4 (0.6, 3.2) | 2.0 (0.9, 4.6) | 2.4 (1.2, 5.1) |  |
 Median survival | 1.72 (1.52, 2.01) | 1.87 (1.32, 2.62) | 2.58 (2.02, 4.40) | 2.80 (2.57, 3.26) | .004§ |
 Adjusted hazard ratioa | 1.00 (ref) | 0.96 (0.76, 1.21) | 0.84 (0.65, 1.10) | 0.78 (0.66, 0.91) ** | .01¶ |
Lactate clearance; mg/dl |  |  |  |  | < .001‡ |
N | 207 | 97 | 62 | 400 | Â |
 Median (Q1, Q3) | 0.5 (− 0.1, 1.3) | 0.4 (− 0.05, 1.2) | 0.6 (− 0.04, 1.2) | 0.2 (− 0.4, 0.8) |  |
 Adjusted mean estimate c | 0.00 (ref) | 0.05 (− 0.27, 0.38) | 0.13 (− 0.25, 0.52) | − 0.45 (− 0.68, − 0.23)*** | < .001¶ |
MAP change in the first 3 h; mmHg |  |  |  |  | < .001 ‡ |
N | 254 | 120 | 79 | 508 | Â |
 Median (Q1, Q3) | 4.3 (− 3.0, 11.5) | 4.0 (− 4.5, 11.5) | − 0.5 (− 10.5, 7.0) | 0.5 (− 5.5, 7.0) |  |
 Adjusted mean estimatec | 0.00 (ref) | − 1.14 (− 4.25, 1.96) | − 3.55 (− 7.17, 0.07) | − 2.93 (− 5.10, − 0.75)** | .04¶ |
HR change in the first 3 h; bpm |  |  |  |  | .2‡ |
N | 255 | 120 | 82 | 545 | Â |
 Median (Q1, Q3) | − 2.0 (− 7.5, 2.5) | − 2.3 (− 8.0, 4.3) | − 2.5 (− 9.5, 0.5) | − 1.5 (− 7.5, 3.5) |  |
 Adjusted mean estimatec | 0.00 (ref) | 0.50 (− 2.06, 3.07) | − 1.41 (− 4.37, 1.54) | 1.63 (− 0.15, 3.41) | .08¶ |
Fluid balance at T3; ml/kg | 59 (45, 79) | 44 (35, 60) | 33 (31, 41) | 7 (1, 15) | < .001‡ |
 Adjusted mean estimatec | 0.00 (ref) | 14.61 (10.63, 18.59)*** | 28.73 (24.23, 33.22)*** | 57.08 (54.34, 59.82)*** | < .001¶ |
MICU fluid balance; ml/kg | 76 (48, 136) | 71 (40, 125) | 66 (24, 146) | 50 (16, 110) | < .001‡ |
 Adjusted mean estimatec | 0.00 (ref) | − 10 (− 34, 14) | − 6 (− 33, 21) | 13 (− 4, 29) | .1¶ |
Fluid infusion between T3 and MICU discharge; ml/kg | 107 (50, 264) | 124 (49, 223) | 158 (62, 381) | 168 (86, 345) | < .001‡ |
 Adjusted mean estimatec | 0.00 (ref) | − 54 (− 102, − 5)* | 37 (− 18, 91) | 59 (27, 90)*** | < .001¶ |
Duration between first vasopressor using and T0; hours |  |  |  |  | < .001‡ |
N | 233 | 102 | 75 | 502 | Â |
 Median (Q1, Q3) | 2.0 (0.5, 4.7) | 2.3 (1.3, 3.9) | 3.7 (1.4, 6.7) | 7.0 (2.2, 17.7) |  |
 Adjusted mean estimatec | 0.00 (ref) | − 3.8 (− 12.5, 5.0) | − 2.0 (− 11.7, 7.8) | 10.3 (4.6, 15.9)*** | < .001¶ |
SOFA change (day 2–day 1) |  |  |  |  | < .001‡ |
N | 240 | 114 | 80 | 561 | Â |
 Median (Q1, Q3) | − 3 (− 5, − 1) | −  2 (− 5, − 1) | − 2 (− 3.5, − 0.5) | − 2 (− 4, 0) |  |
 Adjusted mean estimatec | 0.00 (ref) | − 0.09 (− 0.71, 0.53) | 0.85 (0.15, 1.55)* | 0.94 (0.52, 1.36)*** | < .001¶ |
Mechanical ventilation; N (%) | 134 (52%) | 68 (55%) | 55 (63%) | 383 (66%) | .002†|
 Adjusted odds ratiob | 1.00 (ref) | 1.04 (0.63, 1.75) | 1.56 (0.87, 2.83) | 1.91 (1.34, 2.73)*** | .001¶ |
Mechanical ventilation duration; days |  |  |  |  | .002‡ |
N | 134 | 68 | 55 | 383 | Â |
 Median (Q1, Q3) | 3 (1, 7) | 2 (1, 6) | 5 (2, 9) | 4 (2, 8) |  |
 Adjusted mean estimatec | 0.00 (ref) | − 14.95 (− 66.76, 36.87) | 43.67 (− 11.93, 99.27) | 45.07 (9.60, 80.54)* | .01¶ |
Discharge alive from MICU | 238 (93%) | 112 (91%) | 81 (92%) | 481 (82%) | < .001†|
 Median survival; days | 2.89 (2.64, 3.19) | 3.09 (2.42, 3.86) | 4.06 (3.12, 5.99) | 4.90 (4.51, 5.67) | < .001§ |
 Adjusted hazard ratioa | 1.00 (ref) | 0.95 (0.75, 1.19) | 0.74 (0.57, 0.95)* | 0.58 (0.49, 0.68)*** | < .001¶ |
Discharge alive from hospital | 225 (88%) | 93 (76%) | 68 (77%) | 415 (71%) | < .001†|
 Median survival; days | 10.09 (8.51, 11.80) | 12.51 (9.77, 15.03) | 16.81 (13.66, 21.01) | 17.69 (15.45, 19.96) | < .001§ |
 Adjusted hazard ratioa | 1.00 (ref) | 0.84 (0.66, 1.08) | 0.58 (0.44, 0.76)*** | 0.53 (0.45, 0.63)*** | < .001¶ |
MICU mortality; N (%) | 18 (7%) | 11 (9%) | 7 (8%) | 104 (18%) | < .001†|
 Adjusted odds ratiob | 1.00 (ref) | 1.34 (0.59, 3.03) | 1.12 (0.44, 2.87) | 3.40 (1.95, 5.93)*** | < .001¶ |
Hospital mortality; N (%) | 31 (12%) | 30 (24%) | 20 (23%) | 170 (29%) | < .001†|
 Adjusted odds ratiob | 1.00 (ref) | 2.53 (1.41, 4.52)** | 2.23 (1.17, 4.27)* | 3.51 (2.27, 5.44)*** | < .001¶ |
28-day mortality; N (%) | 41 (16%) | 32 (26%) | 21 (24%) | 199 (34%) | < .001†|
 Adjusted odds ratiob | 1.00 (ref) | 1.97 (1.12, 3.45)* | 1.86 (0.99, 3.51) | 3.19 (2.13, 4.78)*** | < .001¶ |